1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Earnings

Timely Acquisition Keeps Germany's Dermapharm Growing

 
• By Tom Gallen

With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.

Time is money. Alarm clock and euro banknotes.

Acquiring French dietary supplements specialist Arkopharma Group in January helped Germany’s Dermapharm Holding to post a 10.8% rise in sales to €1.14bn ($1.23bn) in 2023.

The addition of Arkopharma more than offset a drop off in revenues from COVID-19 vaccine production

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

More from Business